301
Views
21
CrossRef citations to date
0
Altmetric
REVIEW

Light-emitting diodes in photodynamic therapy in non-melanoma skin cancers – own observations and literature review

, , &
Pages 105-110 | Received 28 Nov 2014, Accepted 26 Jun 2015, Published online: 29 Feb 2016

References

  • Robertson CA, Hawkins Evans D, Abrahamse H. Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photob B. 2009;96:1–8.
  • Ibbotson SH. An overview of topical photodynamic therapy in dermatology. Photodiagnosis Photodyn Ther. 2010;7:16–23.
  • Morton CA. Photodynamic therapy for nonmelanoma skin cancer–and more? Arch Dermatol. 2004;140:116–120.
  • Babilas P, Travnick R, Werner A, Landthaler M, Szeimies RM. Split-face study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system. J Dtsch Dermatol Gest. 2008;6:25–32.
  • Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci. 2004;19:139–149.
  • Moseley H, Allen JW, Ibbotson SH, Lesar A, McNeill A, Camacho-Lopez MA, et al. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy. Br J Dermatol. 2006;154:747–750.
  • Attili SK, Lesar A, McNeill A, Camacho-Lopez M, Moseley H, Ibbotson S, et al. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Br J Dermatol. 2009;161:170–173.
  • Babilas P, Kohl E, Maisch T, Bäcker H, Gross B, Branzan AL, et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol. 2006;154:712–18.
  • Kuijpers DI, Thissen MR, Neumann MH. Basal cell carcinoma: Treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol. 2002;3:247–259.
  • Bahner JD, Bordeaux JS. Non-melanoma skin cancers: Photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. Clin Dermatol. 2013;31:792–798.
  • Sidoroff A, Thaler P. Taking treatment decisions in non-melanoma skin cancer—The place for topical photodynamic therapy (PDT). Photodiagnosis Photodyn Ther 2010;7:24–32.
  • Tehranchinia Z, Rahimi H, Ahadi MS, Ahadi MS. Aminolevulinic Acid-Photodynamic Therapy of Basal Cell Carcinoma and Factors Affecting the Response to Treatment: A Clinical Trial. Indian J Dermatol. 2013;58:327.
  • Christensen E, Mork C, Skogvoll E. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study. Br J Dermatol. 2012;166:1342–1348.
  • Whitaker IS, Shokrollahi K, Jame W, Mishra A, Lohana P, Murison MC. Combined CO2 Laser With Photodynamic Therapy for the Treatment of Nodular Basal Cell Carcinomas. Ann Plast Surg. 2007;59:484–488.
  • de Berker D, McGregor JM, Hughes BR. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156:222–230.
  • Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications – actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27:536–544.
  • Szeimies RM, Radny P, Sebastian M, Borrosch F, Dirschka T, Krähn-Senftleben G, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study. Br J Dermatol. 2010;163:386–394.
  • Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol. 2012;166:137–146.
  • Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, et al. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol. 2013;168:825–836.
  • Lis-Święty A, Brzezińska-Wcisło L, Bergler-Czop B, Wyględowska-Kania M, Syguła E. Comparison of cryotherapy and photodynamic therapy in treatment of actinic keratosis. Post Dermatol Alergol. 2009;26:120–125.
  • Wiegell SR, Heydenreich J, Fabricius S, Wulf HC. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses. Photodermatol Photoimmunol Photomed. 2011;27:280–285.
  • Enk CD, Levi A. Low-irradiance red LED traffic lamps as light source in PDT for actinic keratoses. Photodermatol Photoimmunol Photomed. 2012;28:332–334.
  • Morton C, Campbell S, Gupta G, Keohane S, Lear J, Zaki I, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamictherapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol. 2006;155:1029–1036.
  • Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol. 2000;143:767–772.
  • Kim SK, Park JY, Song HS, Kim YS, Kim YC. Photodynamic therapy with ablative carbon dioxide fractional laser for treating Bowen disease. Ann Dermatol. 2013;25:335–339.
  • López N, Meyer-Gonzalez T, Herrera-Acosta E, Bosch R, Castillo R, Herrera E. Photodynamic therapy in the treatment of extensive Bowen's disease. J Dermatolog Treat 2012;23:428–430.
  • Fink-Puches R, Soyer HP, Hofer A, Kerl H, Wolf P. Long-term follow up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol. 1998;134:821–826.
  • Wang I, Bendsoe N, Klinteberg CA, Enejder AM, Andersson-Engels S, Svanberg S, Svanberg K. Photodynamic therapy vs cryosurgery of basal cell carcinoma: Result of phase III clinical trial. Br J Dermatol. 2001;144:832–840.
  • Soler AM, Angell-Petersen E, Warloe T, Tausjø J, Steen HB, Moan J, Giercksky KE. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol. 2000;71:724–729.
  • Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmmunol Photomed. 2003;19:134–141.
  • Babilas P, Knobler R, Hummel S, Gottschaller C, Maisch T, Koller M, et al. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol. 2007;157:111–117.
  • Vinciullo C, Elliott T, Francis D, Gebauer K, Spelman L, Nguyen R, et al. Photodynamic therapy with topical methyl aminolaevulinate for ‘difficult-to-treat’ basal cell carcinoma. Br J Dermatol. 2005;152:765–772.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.